|
gptkb:tirzepatide
|
weight loss
|
|
gptkb:Superlative_Chronometer_certification
|
dial text 'Superlative Chronometer Officially Certified'
|
|
gptkb:Adakveo
|
prevention of vaso-occlusive crises
|
|
gptkb:SDG_Indicators
|
231
|
|
gptkb:Euro_NCAP_5-star_rating
|
highest level of safety
|
|
gptkb:Dupixent_(dupilumab)
|
gptkb:prurigo_nodularis
|
|
gptkb:Zolpimist
|
insomnia
|
|
gptkb:casirivimab/imdevimab
|
post-exposure prophylaxis of COVID-19
|
|
gptkb:Tantrums
|
Developmental disorders
|
|
gptkb:EXPAREL
|
post-surgical pain management
|
|
gptkb:Forward_Explicit_Congestion_Notification
|
congestion in the network
|
|
gptkb:Methylnaltrexone
|
opioid-induced constipation in adults with chronic non-cancer pain
|
|
gptkb:Orenitram
|
pulmonary arterial hypertension
|
|
gptkb:G_Mark_symbol
|
product compliance with Gulf Technical Regulation
|
|
gptkb:Dynavel_XR
|
gptkb:attention_deficit_hyperactivity_disorder
|
|
gptkb:antifibrinolytics
|
surgical bleeding
|
|
gptkb:CIMERLI
|
gptkb:neovascular_(wet)_age-related_macular_degeneration
|
|
gptkb:Global_Ranking_of_Academic_Subjects
|
quality of research
|
|
gptkb:URAP
|
citation impact total
|
|
gptkb:Lynparza
|
pancreatic cancer
|